Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 265-268

  Chitalia, Nihil ^a   Recio Mayoral, Alejandro ^a   Kaski, Juan Carlos ^a   Banerjee, Debasish ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Chronic kidney disease; Endothelial dysfunction; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERY BLOOD FLOW; ARTICLE; BODY MASS; BRACHIAL ARTERY; CHEMOLUMINESCENCE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERTENSION; IMMUNOASSAY; MALE; PRIORITY JOURNAL; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOASSAY; KIDNEY DISEASES; LONDON; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; VASODILATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84155162421     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.023     Document Type: Article

References (33)

1. Becker B.N., Himmelfarb J., Henrich W.L., Hakim R.M. Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors. J Am Soc Nephrol 1997, 8:475-486.
2. Cheung A.K., Sarnak M.J., Yan G., et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000, 58:353-362.
3. Stenvinkel P., Heimburger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
4. Ambrus C., Almasi C., Berta K., et al. Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 2011, 43:475-482.
5. Matias P.J., Jorge C., Ferreira C., et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010, 5:905-911.
6. Wolf M., Shah A., Gutierrez O., et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007, 72:1004-1013.
7. Gokce N., Keaney J.F., Hunter L.M., et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003, 41:1769-1775.
8. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001, 104:2673-2678.
9. Yilmaz M.I., Stenvinkel P., Sonmez A., et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Nephrol Dial Transplant 2011, 26(11):3537-3543.
10. Young J.M., Terrin N., Wang X., et al. Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:1115-1120.
11. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001, 358:2113-2117.
12. Pannier B., Guerin A.P., Marchais S.J., Metivier F., Safar M.E., London G.M. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. Kidney Int 2000, 57:1091-1099.
13. Recio-Mayoral A., Banerjee D., Streather C., Kaski J.C. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011, 216:446-451.
14. Ghiadoni L., Virdis A., Magagna A., Taddei S., Salvetti A. Effect of the angiotensin II type 1 receptor blocker candesartan on endothelial function in patients with essential hypertension. Hypertension 2000, 35:501-506.
15. Luscher T.F., Pieper M., Tendera M., et al. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Eur Heart J 2009, 30:1590-1597.
16. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996, 94:258-265.
17. Beckman J.A., Liao J.K., Hurley S., et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res 2004, 95:217-223.
18. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxy vitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620.
19. Masci P.G., Laclaustra M., Lara J.G., Kaski J.C. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005, 95:1478-1480.
20. Newey V.R., Nassiri D.K. Online artery diameter measurement in ultrasound images using artificial neural networks. Ultrasound Med Biol 2002, 28:209-216.
21. Elamin M.B., bu Elnour N.O., Elamin K.B., et al. Vitamin d and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:1931-1942.
22. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin d deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
23. Merke J., Milde P., Lewicka S., et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989, 83:1903-1915.
24. O'Connell T.D., Berry J.E., Jarvis A.K., Somerman M.J., Simpson R.U. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997, 272:H1751-H1758.
25. Somjen D., Weisman Y., Kohen F., et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111:1666-1671.
26. Jablonski K.L., Chonchol M., Pierce G.L., Walker A.E., Seals D.R. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011, 57:63-69.
27. Peelen E., Knippenberg S., Muris A.H., et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011, 10(12):733-743.
28. Takeda M., Yamashita T., Sasaki N., et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 2010, 30:2495-2503.
29. Kandula P., Dobre M., Schold J.D., Schreiber M.J., Mehrotra R., Navaneethan S.D. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011, 6:50-62.
30. Bodyak N., Ayus J.C., Achinger S., et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A 2007, 104:16810-16815.
31. Perticone F., Ceravolo R., Pujia A., et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001, 104:191-196.
32. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000, 101:1899-1906.
33. Nanayakkara P.W., van G.C., ter Wee P.M., et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Arch Intern Med 2007, 167:1262-1270.